301331 恩威醫藥
按盤價 
24.860 +0.370 (+1.511%)
24.860 +0.370 (+1.511%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.073 | 7.651 | 7.553 | 16.559 | 19.916 |
| 總資產報酬率 ROA (%) | 1.596 | 6.292 | 5.960 | 11.844 | 12.363 |
| 投入資產回報率 ROIC (%) | 1.847 | 7.430 | 7.280 | 15.888 | 19.092 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.952 | 51.255 | 50.196 | 56.342 | 57.462 |
| 營業利潤率 (%) | 5.092 | 12.956 | 11.842 | 17.534 | 19.610 |
| 息稅前利潤/營業總收入 (%) | 4.373 | 12.087 | 11.644 | 17.635 | 19.849 |
| 淨利潤/營業總收入 (%) | 3.930 | 10.993 | 9.804 | 14.968 | 16.586 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.799 | 85.739 | 86.845 | 83.429 | 81.702 |
| 價值變動淨收益/利潤總額(%) | 9.405 | 3.694 | 0.721 | -0.366 | 0.007 |
| 營業外收支淨額/利潤總額(%) | -11.796 | -0.407 | -0.041 | -0.043 | 0.093 | 償債能力分析 |
| 流動比率 (X) | 4.856 | 3.751 | 4.206 | 2.077 | 1.746 |
| 速動比率 (X) | 4.253 | 3.239 | 3.746 | 1.525 | 1.411 |
| 資產負債率 (%) | 28.177 | 17.519 | 17.999 | 26.101 | 30.905 |
| 帶息債務/全部投入資本 (%) | 16.655 | 0.263 | 1.182 | 0.039 | -0.684 |
| 股東權益/帶息債務 (%) | 489.438 | 37,055.882 | 8,176.952 | 246,499.927 | -14,036.701 |
| 股東權益/負債合計 (%) | 254.898 | 470.820 | 455.593 | 283.132 | 223.572 |
| 利息保障倍數 (X) | -24.104 | -14.804 | -60.142 | 163.212 | 89.785 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 47.509 | 43.883 | 45.020 | 38.991 | 46.642 |
| 存貨周轉天數 (天) | 105.537 | 99.708 | 112.181 | 114.250 | 99.476 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
